Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Accidental sulphamethoxazole poisoning |
Causative agent |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
|
Intentional sulfamethoxazole poisoning |
Causative agent |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
|
forgiftning med sulfamethoxazol, uvist med hvilken hensigt |
Causative agent |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
Poisoning by sulfamethoxazole |
Causative agent |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
Sulfamethoxazole 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
|
sulfamethoxazol + trimethoprim 200 mg/40 mg suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
|
sulfamethoxazol + trimethoprim tablet a 400 mg/80 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
|
sulfamethoxazol + trimethoprim tablet a 800 mg/160 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
|
Sulfamethoxazole 400mg/trimethoprim 80mg infusion solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
|
Sulfamethoxazole 80mg/trimethoprim 16mg infusion solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
|
Product containing sulfamethoxazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
Sulfamethoxazole measurement |
Component |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
Product containing sulfamethoxazole and trimethoprim (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
Sulfamethoxazole 100 mg and trimethoprim 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
|
trimethoprim + sulfamethoxazol + phenazopyridinhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
|
Phenazopyridine hydrochloride 200 mg and sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
|
Product containing phenazopyridine and sulfamethoxazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
2 |
azosulfamethoxazol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
|
Accidental sulphamethoxazole poisoning |
Causative agent |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
Intentional sulfamethoxazole poisoning |
Causative agent |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
forgiftning med co-trimoxazol |
Causative agent |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
accidentel forgiftning med co-trimoxazol |
Causative agent |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
tilsigtet forgiftning med co-trimoxazol |
Causative agent |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
forgiftning med co-trimoxazol, uvist med hvilken hensigt |
Causative agent |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
bivirkning af co-trimoxazol |
Causative agent |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
allergi over for sulfamethoxazol og trimethoprim |
Causative agent |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
|
overdosis af co-trimoxazol |
Causative agent |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
accidentel overdosis af co-trimoxazol |
Causative agent |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
tilsigtet overdosis af co-trimoxazol |
Causative agent |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
overdosis af co-trimoxazol, uvist med hvilken hensigt |
Causative agent |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely sulfamethoxazole 400 milligram and trimethoprim 80 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
|
co-trimoxazol 80 mg/400 mg dispergibel tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
|
Sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
|
co-trimoxazol 160 mg/800 mg dispergibel tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
|
co-trimoxazol 40 mg/80 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
|
Sulfamethoxazole 80 mg/mL and trimethoprim 16 mg/mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
|
co-trimoxazol 40 mg/200 mg/5 ml suspension til børn |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
|
co-trimoxazol 16 mg/80 mg/ml koncentrat til infusionsvæske, ampul a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
|
co-trimoxazol 40 mg/200 mg/5 ml sukkerfri suspension til børn |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
|
co-trimoxazol 960 mg/10 ml infusionsvæske til intravenøs anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
|
Product containing sulfamethoxazole and trimethoprim in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
Sulfamethoxazole- and trimethoprim-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
Adverse reaction to sulfamethoxazole |
Causative agent |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
Co-trimoxazole [generic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
|
Co-trimoxazole [proprietary] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
|
co-trimoxazol 16 mg/80 mg/ml infusionsvæske, opløsning, ampul a 20 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
|
allergi over for sulfamethoxazol og trimethoprim |
Causative agent |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
4 |
Sulfamethoxazole and trimethoprim |
Is a |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
|
Product containing precisely sulfamethoxazole 400 milligram and trimethoprim 80 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely sulfamethoxazole 400 milligram and trimethoprim 80 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
2 |
Sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
Sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
Sulfamethoxazole 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
Sulfamethoxazole 500 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
Sulfamethoxazole 100 mg and trimethoprim 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
Sulfamethoxazole 100 mg and trimethoprim 20 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely sulfamethoxazole 400 milligram and trimethoprim 80 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
Phenazopyridine hydrochloride 200 mg and sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
3 |
Phenazopyridine hydrochloride 200 mg and sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
2 |
Phenazopyridine hydrochloride 200 mg and sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
2 |
Sulfamethoxazole 500 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely sulfamethoxazole 400 milligram and trimethoprim 80 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
Sulfamethoxazole 100 mg and trimethoprim 20 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
Phenazopyridine hydrochloride 200 mg and sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
3 |
Sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
Sulfamethoxazole 80 mg/mL and trimethoprim 16 mg/mL oral suspension |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
2 |
Sulfamethoxazole 80 mg/mL and trimethoprim 16 mg/mL oral suspension |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
2 |
Sulfamethoxazole and trimethoprim |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
|
Product containing precisely sulfamethoxazole 800 milligram/10 milliliter and trimethoprim 160 milligram/10 milliliter conventional release solution for infusion ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely sulfamethoxazole 800 milligram/10 milliliter and trimethoprim 160 milligram/10 milliliter conventional release solution for infusion ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
2 |
Sulfamethoxazole 40 mg/mL and trimethoprim 8 mg/mL oral suspension |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
Sulfamethoxazole 40 mg/mL and trimethoprim 8 mg/mL oral suspension |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
Product containing phenazopyridine and sulfamethoxazole and trimethoprim in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
2 |
Product containing sulfamethoxazole in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
Phenazopyridine- and sulfamethoxazole- and trimethoprim-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
2 |
Phenazopyridine and sulfamethoxazole only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
2 |
Phenazopyridine and sulfamethoxazole and trimethoprim only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
2 |
Sulfamethoxazole only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
Product containing only sulfamethoxazole and trimethoprim (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
Product containing only phenazopyridine and sulfamethoxazole and trimethoprim in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
2 |
Sulfamethoxazole and trimethoprim only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
Sulfamethoxazole and trimethoprim only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
Product containing only sulfamethoxazole in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
Sulfamethoxazole 80 mg/mL and trimethoprim 16 mg/mL solution for infusion |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
Sulfamethoxazole 80 mg/mL and trimethoprim 16 mg/mL solution for infusion |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
allergi over for sulfamethoxazol og trimethoprim |
Causative agent |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
2 |
Sulfamethoxazole 80 mg/mL and trimethoprim 16 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
Sulfamethoxazole 80 mg/mL and trimethoprim 16 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
Sulfamethoxazole 80 mg/mL and trimethoprim 16 mg/mL oral suspension |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
Sulfamethoxazole 80 mg/mL and trimethoprim 16 mg/mL oral suspension |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
Phenazopyridine hydrochloride 200 mg and sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
Phenazopyridine hydrochloride 200 mg and sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
Product containing isoniazid and pyridoxine and sulfamethoxazole and trimethoprim (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
Product containing only isoniazid and pyridoxine and sulfamethoxazole and trimethoprim (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
Isoniazid- and pyridoxine- and sulfamethoxazole- and trimethoprim-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
Isoniazid and pyridoxine and sulfamethoxazole and trimethoprim only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely isoniazid 300 milligram and pyridoxine hydrochloride 25 milligram and sulfamethoxazole 800 milligram and trimethoprim 160 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely isoniazid 300 milligram and pyridoxine hydrochloride 25 milligram and sulfamethoxazole 800 milligram and trimethoprim 160 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely sulfamethoxazole 80 milligram/1 milliliter and trimethoprim 16 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely sulfamethoxazole 80 milligram/1 milliliter and trimethoprim 16 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |